CAMK2G and attention deficit-hyperactivity disorder: Dysregulation of CaMKII has been observed in neurological diseases including ADHD (Yabuki et al., 2014), Parkinson’s disease (Zaichick et al., 2017), and Alzheimer’s disease (Ghosh and Giese, 2015).